Literature DB >> 8777928

A survey of the management of neonatal opiate withdrawal in England and Wales.

C L Morrison1, C Siney.   

Abstract

UNLABELLED: This report details the results of a survey of 213 maternity units in England and Wales concerning the use of neonatal opiate withdrawal (NOW) charts and the drug therapy management of babies born to drug using mothers. There was a response rate of 89.6%. NOW charts were used in 36.6% of units. There were eight different charts in use in which over 35 different signs of NOW were recorded, ranging from 10 to 22 on individual charts. Nine different drugs were used to manage NOW, with chlorpromazine most commonly used.
CONCLUSION: Drug misuse increasing in women of childbearing age and the management of the drug affected neonate varies widely, with inconsistent policies on determining the presence of NOW and how to treat it.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777928     DOI: 10.1007/bf02002721

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

1.  Infants of drug-addicted mothers.

Authors:  D Thomas
Journal:  Aust Paediatr J       Date:  1988-06

2.  Neonatal opiate withdrawal.

Authors:  R P Rivers
Journal:  Arch Dis Child       Date:  1986-12       Impact factor: 3.791

3.  Maternal narcotic abuse and the newborn.

Authors:  L G Alroomi; J Davidson; T J Evans; P Galea; R Howat
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

4.  Neonatal abstinence syndrome after maternal methadone treatment.

Authors:  N J Shaw; L McIvor
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

5.  Neonatal opiate abstinence syndrome in term and preterm infants.

Authors:  T M Doberczak; S R Kandall; I Wilets
Journal:  J Pediatr       Date:  1991-06       Impact factor: 4.406

  5 in total
  8 in total

Review 1.  Drug misusing parents: key points for health professionals.

Authors:  J Keen; L H Alison
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

2.  What is the best evidence based management of neonatal abstinence syndrome?

Authors:  N Nandakumar; V S Sankar
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

Review 3.  Treatment of neonatal abstinence syndrome.

Authors:  K Johnson; C Gerada; A Greenough
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

4.  Skin conductance in neonates suffering from abstinence syndrome and unexposed newborns.

Authors:  Nicola Elisabeth Schubach; Katrin Mehler; Bernhard Roth; Eckhard Korsch; Rainhard Laux; Dominique Singer; Axel von der Wense; András Treszl; Christoph Hünseler
Journal:  Eur J Pediatr       Date:  2016-03-30       Impact factor: 3.183

5.  Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital.

Authors:  Adam Newman; Gregory A Davies; Kimberly Dow; Belinda Holmes; Jessica Macdonald; Sarah McKnight; Lynn Newton
Journal:  Can Fam Physician       Date:  2015-12       Impact factor: 3.275

6.  A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome.

Authors:  L Jackson; A Ting; S McKay; P Galea; C Skeoch
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

7.  Variations and similarities in clinical management of neonatal abstinence syndrome: Findings of a Canadian survey.

Authors:  Katie Murphy; Helen Coo; Ruth Warre; Vibhuti Shah; Kimberly Dow
Journal:  Paediatr Child Health       Date:  2017-05-15       Impact factor: 2.253

8.  Treatment of opioid withdrawal in neonates with morphine, phenobarbital, or chlorpromazine: a randomized double-blind trial.

Authors:  Urs Zimmermann; Christoph Rudin; Angelo Duò; Leonhard Held; Hans Ulrich Bucher
Journal:  Eur J Pediatr       Date:  2019-11-06       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.